Yahoo Web Search

Search results

  1. Jan 18, 2023 · David Evans Shaw is an American businessman famous as managing partner of investment firmBlack Point Group.’ Shaw was the founding Chairman and CEO of IDEXX Laboratories Inc; founding CEO and Executive Chair of Ikaria Pharma; and co-founder and chairman of Direct Vet Marketing.

  2. David E. Shaw is a prominent American business and social entrepreneur with global leadership experience in science-based companies, investment management and social impact NGOs. He is the founder of IDEXX Laboratories, co-founder of Covetrus, and a board member or advisor of many organizations in science, conservation, arts, and public policy.

  3. David Evans Shaw is a social and business entrepreneur, founder of IDEXX Laboratories, and leader of several science-based ventures and public service organizations. He has received many honors and awards, and is active in arts, conservation, and neuroplasticity research.

  4. David Evans Shaw is an American entrepreneur, investor and activist. He is the founder and CEO of Black Point Group and founder of IDEXX Laboratories in Maine. In a 2021 article, the Portland Press Herald described him as Shaw is also known for his public service, as well as his support of the arts and environmental stewardship

  5. David Elliot Shaw (born March 29, 1951) is an American billionaire scientist and former hedge fund manager. He founded D. E. Shaw & Co., a hedge fund company which was once described by Fortune magazine as "the most intriguing and mysterious force on Wall Street".

  6. www.deshaw.com › who-we-are › founderThe D. E. Shaw Group

    The vast majority of his time is now devoted to his role as chief scientist of D. E. Shaw Research,LLC, in which capacity he leads an interdisciplinary research group in the field of computational biochemistry and personally engages in hands-on scientific research in that field.

  7. People also ask

  8. Apr 7, 2021 · David Evans Shaw, a pharmaceutical investor-entrepreneur and public service champion, has invested in Maxwell Biosciences to advance its anti-infectives program. Maxwell Biosciences develops a new class of antiviral drugs that destroy a broad spectrum of viruses, including SARS-CoV-2, Hepatitis B & C, and Herpes.